NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 22 filers reported holding NEUROBO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $28,000 | -46.2% | 57,425 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $52,000 | -25.7% | 57,425 | 0.0% | 0.01% | -14.3% |
| Q4 2021 | $70,000 | -67.3% | 57,425 | 0.0% | 0.01% | -72.0% |
| Q3 2021 | $214,000 | +12.0% | 57,425 | 0.0% | 0.02% | +8.7% |
| Q2 2021 | $191,000 | – | 57,425 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mount Yale Investment Advisors, LLC | 57,425 | $214,000 | 0.02% |
| UBS Group AG | 1,037 | $4,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 371 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 323 | $1,000 | 0.00% |
| NORTHERN TRUST CORP | 24,642 | $92,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 728 | $3,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 60,792 | $226,000 | 0.00% |
| STATE STREET CORP | 15,878 | $59,000 | 0.00% |
| MORGAN STANLEY | 141 | $0 | 0.00% |